CardioVascular BioTherapeutics (fka CVBT)

[walhall]

Question 4: Starting in what years did Venturis Therapeutics / Cardiovascular Biotherapeutics publicly indicate its clinical trials would be re-commencing after an absence of all clinical trial activity since 2007?

A) 2018
B) 2019
C) 2020
D) 2021
E) All of the above
F) A, B, and C

(The correct answer is at the bottom of this posting)

This is part of our new Venturis Therapeutics educational trivia series. It's educational and fun for the whole family while we're all social distancing!

For more information:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=155716827

The correct answer is: (F) 2018, 2019, and 2020. Yes, we shareholders have been publicly and very falsely told that the clinical trials would re-start in 2018, then in 2019, then in 2020….but we’ve never ONCE been told why any of those promised dates never materialized, and to this date, not a single clinical trial has been run since 2007. Rather, the stance from Calvin Wallen III and Grant Gordon has been to act as if everything is on schedule and no promises were ever made and subsequently broken. Is it possible that one of them was too drunk to even notice?

If you chose (E), the judges will still award you half a point. Unfortunately Venturis Therapeutics hasn’t yet told us that the trials will be re-starting in 2021, likely because they have not held the 2020 annual shareholders meeting as they were supposed to where we would have been told that lie. But this is a reasonable answer, so it's worth half a point.